glp 1 for sleep apnea Efficacy of GLP-1 Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes Can GLP-1's Help Fight Sleep

The class III segment dominated the GLP-1 targeted peptide weight loss drugs market in 2024 because individuals with severe obesity have the greatest clinical need and are more likely to be prescribed effective pharmacological treatments

Patients with a personal or family history of medullary thyroid cancer should never take GLP-1 drugs because animal studies showed these medications may increase thyroid cancer risk in this specific population

A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. According to the WHO the rate of obesity worldwide doubled in adults and quadrupled in adolescents between 1990 and 2022

Insufficient/not enough sleep and stress are key dysregulators of weight, insulin sensitivity and inflammation in the body, all things we are trying to optimize with GLPs

Oral semaglutide likewise resulted in reductions in weight during the trial